Nephros, Inc.
NEPH
$1.63
$0.00990.61%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 0.03% | 12.79% | 22.14% | 42.72% | 33.67% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.03% | 12.79% | 22.14% | 42.72% | 33.67% |
| Cost of Revenue | -6.59% | -5.08% | -2.70% | 10.96% | 3.65% |
| Gross Profit | 4.76% | 28.68% | 46.81% | 78.11% | 68.62% |
| SG&A Expenses | -0.87% | 9.35% | 18.44% | 17.37% | 8.65% |
| Depreciation & Amortization | -30.59% | -18.40% | -7.66% | 3.88% | 14.06% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.43% | 1.44% | 6.45% | 10.62% | 4.73% |
| Operating Income | 41.36% | 49.58% | 51.94% | 63.25% | 62.48% |
| Income Before Tax | 43.35% | 52.22% | 52.42% | 63.18% | 61.71% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 43.35% | 52.22% | 52.42% | 63.18% | 61.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 95.72% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | 73.78% |
| Net Income | 49.48% | 73.53% | 74.58% | 78.66% | 75.70% |
| EBIT | 41.36% | 49.58% | 51.94% | 63.25% | 62.48% |
| EBITDA | 43.13% | 51.37% | 53.51% | 65.39% | 64.32% |
| EPS Basic | 50.17% | 73.97% | 74.87% | 78.89% | 75.88% |
| Normalized Basic EPS | 46.74% | 56.75% | 57.68% | 66.97% | 63.94% |
| EPS Diluted | 55.91% | 74.20% | 75.03% | 79.33% | 71.54% |
| Normalized Diluted EPS | 46.74% | 56.75% | 57.68% | 66.97% | 63.94% |
| Average Basic Shares Outstanding | 1.53% | 1.72% | 1.20% | 0.91% | 0.96% |
| Average Diluted Shares Outstanding | 1.62% | 1.72% | 1.20% | 0.91% | 0.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
